# Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

> **NCT01726582** · PHASE2 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 229 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** Milestone 1: Targeted chemotherapy prior to surgery
- **RADIATION:** Milestone 2: Chemoradiotherapy (cXRT)
- **DRUG:** Milestone 3: Targeted chemotherapy prior to surgery
- **RADIATION:** Milestone 3: Chemoradiotherapy (cXRT)
- **DRUG:** Milestone 4: standard FOLFIRINOX chemotherapy prior to surgery
- **RADIATION:** Milestone 4: Chemoradiotherapy (cXRT)
- **DRUG:** Milestone 5: Targeted chemotherapy after surgery
- **RADIATION:** Milestone 5: Chemoradiotherapy (cXRT)
- **DRUG:** Milestone 6: Gemcitabine after surgery
- **RADIATION:** Milestone 6: Chemoradiotherapy (cXRT)
- **RADIATION:** Milestone 7: Chemoradiotherapy (cXRT)
- **DRUG:** Milestone 8: Targeted chemotherapy after surgery
- **DRUG:** Milestone 9: Gemcitabine after surgery
- **OTHER:** Milestone 10: No additional therapy after surgery

## Key facts

- **NCT ID:** NCT01726582
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2018-06
- **Final completion:** 2022-04-11
- **Target enrollment:** 229 (ACTUAL)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01726582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01726582, "Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01726582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*